✦ LIBER ✦

Efficacy of Amphotericin B Colloidal Dispersion in the Treatment of Mediterranean Visceral Leishmaniasis in Immunocompetent Adult Patients

✍ Scribed by Giovanni B. Gaeta, Angela Maisto, D,

Book ID: 120455552
Publisher: Informa plc
Year: 2000
Tongue: English
Weight: 117 KB
Volume: 32
Category: Article
ISSN: 0036-5548
DOI: 10.1080/003655400459612

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Amphotericin B colloidal dispersion in v

Amphotericin B colloidal dispersion in visceral leishmaniasis

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Liposomal amphotericin B in the treatmen

Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients

✍ E. Vigna; A. De Vivo; M. Gentile; R. Morelli; E. Lucia; C. Mazzone; A.G. Recchia 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Retrospective analysis of visceral leish

Retrospective analysis of visceral leishmaniasis relapses in immunocompetent patients who received treatment with 20mg/kg liposomal amphotericin B in Bihar, India

✍ S. Burza; P.K. Sinha; P. Das; R. Mahajan; M. Gonzalez; G. Mitra; M.A. Lima; P.P. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 90 KB

A novel mechanism for an old drug: Ampho

A novel mechanism for an old drug: Amphotericin B in the treatment of visceral leishmaniasis

✍ Amitabha Chattopadhyay; Md. Jafurulla 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 661 KB

Lipid formulations of amphotericin B in

Lipid formulations of amphotericin B in the treatment of experimental visceral leishmaniasis due to Leishmania infantum

✍ Jean-Pierre Gangneux; Annie Sulahian; Yves Jean-François Garin; Francis Derouin 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 590 KB

Dose-ranging studies on liposomal amphot

Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis

✍ P.V. Bodhe; R.N. Kotwani; B.G. Kirodian; A.V. Pathare; A.K. Pandey; C.P. Thakur; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 537 KB

Efficacy and tolerability of liposomal amphotericin B (LAMP-LRC-1; developed in India by the Liposome Clinical Pharmacology Centre, Mumbai, and the Liposome Research Centre, New Delhi) were assessed in 63 patients suffering from visceral leishmaniasis at centres in Mumbai and Pama. Patients were tre